Fluorescent imaging with substituted cyanine dyes
Compounds and methods are disclosed that are useful for noninvasive imaging in the near-infrared spectral range. The cyanine compounds of Formula I are presented: wherein Q is a portion of a polymethine bridge: Also included are bioconjugates of the compounds of Formula I, methods of labeling biomolecules with the compounds, and methods of imaging.
1. A near-infrared (NIR) compound of the formula:
wherein R 1 is LYZ;
L is an optional member selected from the group consisting of a bond, a C 1 -C 20 alkylene, and a C 1 -C 20 alkenylene; wherein the alkylene or alkenylene is optionally interrupted by at least one heteroatom;
Y is an optional member selected from the group consisting of a bond, —O—, —S—, —NH—, —NHC(O)—, —C(O)NH—, —NR 15 —, —NR 15 C(O)—, —C(O)NR 15 —, —N(Z)—, —N(Z)C(O)—, and —C(O)N(Z)—;
R 15 is a member selected from the group consisting of alkyl and alkoxycarbonylalkyl, wherein the alkyl is optionally interrupted by at least one heteroatom;
Z is R 16 ;
or alternatively, —Y—Z is a member selected from the group consisting of —N(Z) 2 , —N(Z)C(O)Z, and —C(O)N(Z) 2 , and the two Z groups may optionally be linked to form a cycloalkynyl group; and
R 16 is member selected from the group consisting of azido, alkynyl, a pegylated azido, a pegylated alkynyl, a pegylated cycloalkynyl, a pegylated spirocycloalkynyl, an o -diarylphosphino aryl ester, and an ortho substituted phosphine oxide aryl ester, DBCO, DBCO-1, TPPME, BARAC, DIFO, BCN, DIBO, TMDIBO and DIFO3, wherein the compound has emission in the near-infrared.
2. The compound of claim 1 , wherein R 16 is member selected from the group consisting of azido, alkynyl, a pegylated azido, and a pegylated alkynyl.
3. The compound of claim 2 , wherein R 16 is azido.
4. The compound of claim 2 , wherein R 16 is alkynyl.
5. The compound of claim 1 , wherein R 16 is member selected from the group consisting of DBCO, DBCO-1, TPPME, BARAC, DIFO, BCN, DIBO, TMDIBO and DIFO3.
6. The compound of claim 5 , wherein R 16 is DBCO or DBCO-1.
7. The compound of claim 5 , wherein R 16 is DBCO.
8. The compound of claim 1 , wherein said compound has the formula:
9. The compound of claim 1 , wherein said compound has the formula:
10. A method for imaging, said method comprising: administering a compound having the formula:
wherien R 1 is LYZ;
L is an optional member selected from the group consisting of a bond, a C 1 -C 20 alkylene, and a C 1 -C 20 alkenylene; wherein the alkylene or alkenylene is optionally interrupted by at least one heteroatom;
Y is an optional member independently selected from the group consisting of a bond, —O—, —S—, —NH—, —NHC(O)—, —C(O)NH—, —NR 15 —, —NR 15 C(O)—, —C(O)NR 15 —, —N(Z)—, —N(Z)C(O)—, and —C(O)N(Z)—;
R 15 is a member selected from the group consisting of alkyl and alkoxycarbonylalkyl, wherein the alkyl is optionally interrupted by at least one heteroatom;
Z is -L-R 16 ;
or alternatively, —Y—Z is a member selected from the group consisting of —N(Z) 2 , —N(Z)C(O)Z, and —C(O)N(Z) 2 , and the two Z groups may optionally be linked to form a cycloalkynyl group;
R 16 is member selected from the group consisting of azido, alkynyl, a pegylated azido, a pegylated alkynyl, a pegylated cycloalkynyl, a pegylated spirocycloalkynyl, an o -diarylphosphino aryl ester, and an ortho substituted phosphine oxide aryl ester, DBCO, DBCO-1, TPPME, BARAC, DIFO, BCN, DIBO, TMDIBO and DIFO3, detecting said compound in a tissue or organism.
11. The method of imaging of claim 10 , wherein said method further comprises detecting said compound in a living organism.
12. The method of imaging of claim 10 , wherein the method comprises a step of imaging a tumor, tissue, or organ.
13. The method of imaging of claim 12 , wherein the tumor, tissue, or organ is selected from the group consisting of vascular endothelial tissue, an abnormal vascular wall of a tumor, a solid tumor, a tumor of the head, a tumor of the neck, a tumor of the gastrointestinal tract, a tumor of the liver, a tumor of the breast, a tumor of the prostate, a tumor of the ovary, a tumor of the uterus, a tumor of the testicle, a tumor of the lung, a nonsolid tumor, a malignant hematopoietic cell, a malignant lymphoid cell, a lesion in the vascular system, a diseased bone marrow, neuronal tissue, diseased neuronal tissue, and diseased cells in which the disease is an autoimmune disease or an inflammatory disease.
14. The method of claim 10 , wherein the compound is used as a detectable tracer element in a biological or non-biological fluid.
15. The method of claim 10 , wherein the compound is used to enhance visualization of chorioretinal diseases, vascular disorders, retinopathies, neovascularization, or ocular tumors; and wherein the method comprises direct microscopic imaging.
16. The method of claim 10 , wherein the compound is used to enhance visualization of skin diseases or skin tumors; and wherein the method comprises direct microscopic imaging.
17. The method of claim 10 , wherein the compound is used to enhance visualization of a gastrointestinal disease, a gastrointestinal tumors, an oral disease, an oral tumor, a bronchial disease, a bronchial tumor, a cervical disease, cervical tumor, a urinary disease, or a urinary tumor; and wherein the method comprises endoscopy.
18. The method of claim 10 , wherein R 16 is member selected from the group consisting of azido, alkynyl, a pegylated azido, and a pegylated alkynyl.
19. The method of claim 10 , wherein R 16 is azido.
20. The method of claim 10 , wherein R 16 is alkynyl.
21. The method of claim 10 , wherein R 16 is member selected from the group consisting of DBCO, DBCO-1, TPPME, BARAC, DIFO, BCN, DIBO, TMDIBO and DIFO3.
22. The method of claim 10 , wherein R 16 is member selected from the group consisting of DBCO, and DBCO-1.
23. The method of claim 10 , wherein R 16 is DBCO.
24. The method of claim 10 , wherein said compound has the formula:
25. The method of claim 10 , wherein said compound has the formula: